Impaired ALDH2 activity decreases the mitochondrial respiration in H9C2 cardiomyocytes

Area of Science:

• Cardiovascular Research
• Mitochondrial Biology
• Cellular Stress Response

Background:

• Reactive aldehydes, such as 4-hydroxy-2-nonenal (4HNE), are implicated in cardiovascular diseases.
• 4HNE contributes to pathogenesis by inducing cellular stress, ROS formation, and impaired mitochondrial respiration.
• The aldehyde dehydrogenase (ALDH) superfamily detoxifies aldehydes, with ALDH2 being crucial for cellular defense.

Purpose of the Study:

• To investigate the hypothesis that 4HNE impairs mitochondrial respiration and causes cell death by inhibiting ALDH2 activity.
• To examine the effects of 4HNE on ALDH2 activity and function in H9C2 cardiomyocytes.

Main Methods:

• H9C2 cardiomyocytes were treated with varying concentrations of 4HNE or the ALDH2 inhibitor disulfiram (DSF).
• ALDH2 activity, protein levels, mitochondrial respiration, and cell death were assessed.
• ALDH2 inhibition was further confirmed using ALDH2 siRNA.

Main Results:

• 4HNE treatment significantly reduced ALDH2 activity, protein levels, and mitochondrial respiration.
• 4HNE exposure increased 4HNE adduct formation and cardiomyocyte cell death.
• ALDH2 inhibition by DSF or siRNA mimicked these effects, decreasing mitochondrial function and increasing cell death.

Conclusions:

• Impairment of ALDH2 activity by 4HNE leads to compromised mitochondrial respiration.
• ALDH2 dysfunction is a key mechanism contributing to cell death in cardiomyocytes under oxidative stress.
• Targeting ALDH2 may offer therapeutic potential for cardiovascular conditions involving aldehyde toxicity.